EPISODE · Jan 24, 2020 · 4 MIN
Acalabrutinib Alone or in Combination With Obinutuzumab Improves PFS in Treatment-Naïve CLL
from Oncology Learning Network · host HMP Global
Acalabrutinib Alone or in Combination With Obinutuzumab Improves PFS in Treatment-Naïve CLL by HMP Global
Embed this episode
Ready to play
Acalabrutinib Alone or in Combination With Obinutuzumab Improves PFS in Treatment-Naïve CLL
0:00
4:38
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Oncology Learning Network?
This episode is 4 minutes long.
When was this Oncology Learning Network episode published?
This episode was published on January 24, 2020.
Can I download this Oncology Learning Network episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!